Modeling the cost-effectiveness of doubling atorvastatin's dose versus adding niacin ER

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Decision-analytic models are useful tools that are helpful in making formulary decisions and comparing treatment pathways, especially when a level of uncertainty exists as to which clinical strategy is most appropriate for patients with a given health state. The purpose of this article is to provide an example of how a decision-analysis model is designed and interpreted for the treatment of coronary heart disease (CHD). A step-by-step approach to conducting decision analysis is presented so that readers can apply this technique in their own practice settings.

Original languageEnglish (US)
Pages (from-to)730-746
Number of pages17
JournalFormulary
Volume36
Issue number10
StatePublished - 2001

Fingerprint

Decision Support Techniques
Niacin
Cost-Benefit Analysis
Formularies
Uncertainty
Coronary Disease
Decision Making
Health
Therapeutics
Atorvastatin Calcium

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Modeling the cost-effectiveness of doubling atorvastatin's dose versus adding niacin ER. / Olson, B. M.; Malone, Daniel C; Armstrong, Edward P.

In: Formulary, Vol. 36, No. 10, 2001, p. 730-746.

Research output: Contribution to journalArticle

@article{58a27ee538b14285ade2dafb51e43f0d,
title = "Modeling the cost-effectiveness of doubling atorvastatin's dose versus adding niacin ER",
abstract = "Decision-analytic models are useful tools that are helpful in making formulary decisions and comparing treatment pathways, especially when a level of uncertainty exists as to which clinical strategy is most appropriate for patients with a given health state. The purpose of this article is to provide an example of how a decision-analysis model is designed and interpreted for the treatment of coronary heart disease (CHD). A step-by-step approach to conducting decision analysis is presented so that readers can apply this technique in their own practice settings.",
author = "Olson, {B. M.} and Malone, {Daniel C} and Armstrong, {Edward P}",
year = "2001",
language = "English (US)",
volume = "36",
pages = "730--746",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "10",

}

TY - JOUR

T1 - Modeling the cost-effectiveness of doubling atorvastatin's dose versus adding niacin ER

AU - Olson, B. M.

AU - Malone, Daniel C

AU - Armstrong, Edward P

PY - 2001

Y1 - 2001

N2 - Decision-analytic models are useful tools that are helpful in making formulary decisions and comparing treatment pathways, especially when a level of uncertainty exists as to which clinical strategy is most appropriate for patients with a given health state. The purpose of this article is to provide an example of how a decision-analysis model is designed and interpreted for the treatment of coronary heart disease (CHD). A step-by-step approach to conducting decision analysis is presented so that readers can apply this technique in their own practice settings.

AB - Decision-analytic models are useful tools that are helpful in making formulary decisions and comparing treatment pathways, especially when a level of uncertainty exists as to which clinical strategy is most appropriate for patients with a given health state. The purpose of this article is to provide an example of how a decision-analysis model is designed and interpreted for the treatment of coronary heart disease (CHD). A step-by-step approach to conducting decision analysis is presented so that readers can apply this technique in their own practice settings.

UR - http://www.scopus.com/inward/record.url?scp=0034781360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034781360&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034781360

VL - 36

SP - 730

EP - 746

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 10

ER -